Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Important Cancer Therapeutics Under Development To Watch
Seeking Alpha
Tuesday, June 5, 2012 - 9:34am
tags:
cabozantinib, Exelixis, BMS-936558, MDX-1106, cancer, anti-PD-1 immunotherapy, Bristol-Myers Squibb
3 Reasons To Buy Aegerion Pharmaceuticals
Seeking Alpha
Tuesday, June 5, 2012 - 9:33am
tags:
Aegerion, PerkinElmer, Abbott Laboratories
Bristol Immune Drug Success In Cancer May Spur Industry Race
Bloomberg
Monday, June 4, 2012 - 6:03pm
tags:
Bristol-Myers Squibb, lung cancer, skin cancer, kidney cancer
Glaxo Melanoma Drugs Beat Standard Chemotherapy In Study
Bloomberg
Monday, June 4, 2012 - 6:02pm
tags:
GSK, melanoma, dabrafenib, trametinib
Should The J&J Zytiga Trial Have Ended Early?
Pharmalot
Monday, June 4, 2012 - 6:00pm
tags:
JNJ, Zytiga, prostate cancer
Will Shares Of Aastrom Really Triple From Today's Levels Within A Year?
Seeking Alpha
Monday, June 4, 2012 - 5:58pm
tags:
Aastrom Biosciences
[video] Onyx Pharma CEO on New Cancer Drug
CNBC
Monday, June 4, 2012 - 5:57pm
tags:
ONYX Pharmaceuticals, Anthony Coles, Bayer, regorafenib, gastrointestinal cancer
ImmunoGen rises on breast cancer drug data; says Roche plans 3 more T-DM1 studies in 2013
Yahoo/AP
Monday, June 4, 2012 - 5:54pm
tags:
Immunogen, Roche, breast cancer, T-DM1
Study of Treanda shows great promise for Teva's drug
Fierce Pharma
Monday, June 4, 2012 - 5:46pm
tags:
Teva Pharmaceuticals, Treanda, ASCO, non-Hodgkin's lymphoma
J&J should split itself three ways, Goldman analyst says
Fierce Pharma
Monday, June 4, 2012 - 5:45pm
tags:
JNJ
Eli Lilly Launches Amyvid
Yahoo/Zacks
Monday, June 4, 2012 - 5:42pm
tags:
Eli Lilly, Amyvid, Alzheimer's disease
Celegene, Bristol Drugs No Better Than Cheaper Treatments
Bloomberg
Monday, June 4, 2012 - 5:41pm
tags:
Celgene, Bristol-Myers Squibb, Ixempra, Abraxane, breast cancer
Cancer Doctors Push Congress To Help End Drug Shortages
Bloomberg
Monday, June 4, 2012 - 5:40pm
tags:
congress, drug shortages
Pharmacyclics advances after reporting new data for blood cancer drug candidate ibrutinib
Yahoo/AP
Monday, June 4, 2012 - 5:40pm
tags:
blood cancer, Pharmacyclics
3 BOMBS Getting Dropped on Dendreon Now
Wall St. Cheat Sheet
Monday, June 4, 2012 - 5:39pm
tags:
Dendreon, Provenge, prostate cancer
Merck says insomnia drug remained effective full year
Reuters
Monday, June 4, 2012 - 12:45pm
tags:
Merck, insomnia, suvorexant
CytRx falls 12% in morning trading
Marketwatch
Monday, June 4, 2012 - 11:50am
tags:
CytRx, INNO-206, soft tissue sarcomas
4 Speculative Biotech Trades In The Economic Downturn
Seeking Alpha
Monday, June 4, 2012 - 11:49am
tags:
Merck, GSK, XenoPort, Taltorvic, soft tissue sarcomas, Ariad Pharmaceuticals, Horizant, postherpetic neuralgia
Why Comments By Novartis VP Will Send Zalicus' Share Price Up
Seeking Alpha
Monday, June 4, 2012 - 11:12am
tags:
Zalicus, Novartis
ASCO '12: Ariad Pharma Leukemia Drug Posts Improved Response Rates
TheStreet.com
Monday, June 4, 2012 - 10:58am
tags:
ASCO, Ariad Pharma, leukemia, Ponatinib

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.